HR
NDRM

Howe & Rusling’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Howe & Rusling’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250
Closed -$4K – 1112
2015
Q4 		$4K Buy
+250
New +$4.87K ﹤0.01% 714

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Howe & Rusling's NDRM Position: Q1 2016 in Review

Howe & Rusling sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q1 2016, closing a stake of 250 shares — an estimated $4K sold.

Howe & Rusling first reported a position in NDRM in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 50 funds tracked by Wall St. Rank hold NDRM as of Q1 2016.

  • Howe & Rusling reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q1 2016 after selling out during the quarter.
  • Howe & Rusling sold 250 NeuroDerm Ltd. Ordinary Shares shares in Q1 2016, an estimated $4K.
  • Howe & Rusling first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 1 quarter.
  • Howe & Rusling's NeuroDerm Ltd. Ordinary Shares position peaked at $4K in Q4 2015.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q1 2016.

Based on Howe & Rusling's 13F filing for Q1 2016, filed 16 May 2016.